Xvivo Perfusion is a medical technology company based in Gothenburg, Sweden, that develops systems and solutions for preserving and evaluating organs intended for transplantation. Its products include perfusion machines and single-use disposable sets used by transplant centres and clinical teams to keep lungs, kidneys, livers and hearts functioning outside the body while they are assessed. The company serves hospitals and organ procurement organisations, combining hardware, software and consumables that support clinical decision-making before a transplant procedure.
Xvivo Perfusion AB trades under the code 0RKL on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2647 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
32/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-14.7%
From 52-week high-32.0%
MomentumWeak
37/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-12.3%
6-month return-30.7%
12-month, skipping last month33.1%
Stability (higher is calmer)Weak
38/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)45.1%
Worst drawdown, 1 year (smaller is calmer)-32.8%
LiquidityFair
59/100
Moderate trading activity.
See the numbers →
Avg daily value traded1.85M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 162.40 – 314.00Daily closes, split-adjusted
Signals
50-day average245.22
200-day average245.12
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)7.39
Technical summary
Daily
Bearish
3 bullish · 2 neutral · 11 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
222.7
Bearish
EMA 10
221.8
Bearish
SMA 20
220.6
Bearish
EMA 20
225.2
Bearish
SMA 50
245.2
Bearish
EMA 50
238.5
Bearish
SMA 100
254.8
Bearish
EMA 100
246.4
Bearish
SMA 200
245.1
Bearish
EMA 200
246.9
Bearish
Oscillators (daily)
RSI (14)
34.84
Neutral
MACD (12, 26)
-5.96
Bearish
Momentum (12)
1.16
Bullish
Stochastic %K (14)
14.89
Bullish
Williams %R (14)
-85.11
Bullish
CCI (20)
-70.64
Neutral
Pivot points (classic, last session)
S3
190.7
S2
199.9
S1
204.6
Pivot
213.8
R1
218.5
R2
227.7
R3
232.4
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
